Skip to content
10-Q

Quarterly Report

Exousia Bio, Inc. LMMY

0001683168-26-004868

← back to feed
Filed
Jun 16, 2026 12:00 AM ET
Period of report
Jun 15, 2026
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Jun 15, 2026 52.5M sh
Shares Diluted Q3 2026 · Feb 28, 2026 16.76M sh
Shares Diluted Q3 2026 · Feb 28, 2026 12.27M sh
Shares Diluted Q3 2026 · Feb 28, 2025 7.78M sh
Shares Diluted restated Q3 2026 · Feb 28, 2025 7M sh
Capex Q3 2026 · Feb 28, 2026 $670
Capex Q3 2026 · Feb 28, 2025 $0
Operating Cash Flow Q3 2026 · Feb 28, 2026 $176.63K
Operating Cash Flow restated Q3 2026 · Feb 28, 2025 $86.54K
Stockholders Equity Q3 2026 · Feb 28, 2026 $21.79M
Stockholders Equity Q3 2026 · May 31, 2025 $0
Stockholders Equity restated Q3 2026 · Feb 28, 2025 $24.85K
Stockholders Equity Q3 2026 · May 31, 2024 −$54.9K
Current Liabilities Q3 2026 · Feb 28, 2026 $261.02K
Current Liabilities Q3 2026 · May 31, 2025 $0
Total Liabilities Q3 2026 · Feb 28, 2026 $261.02K
Total Liabilities Q3 2026 · May 31, 2025 $0
Current Assets Q3 2026 · Feb 28, 2026 $0
Current Assets Q3 2026 · May 31, 2025 $0
Total Assets Q3 2026 · Feb 28, 2026 $22.05M
Total Assets Q3 2026 · May 31, 2025 $0
Eps Diluted Q3 2026 · Feb 28, 2026 $0.00
Eps Diluted Q3 2026 · Feb 28, 2026 $0.00
Eps Diluted restated Q3 2026 · Feb 28, 2025 $0.01
Eps Diluted Q3 2026 · Feb 28, 2025 $0.00
Eps Basic Q3 2026 · Feb 28, 2026 $0.00
Eps Basic Q3 2026 · Feb 28, 2026 $0.00
Eps Basic restated Q3 2026 · Feb 28, 2025 $0.01
Eps Basic Q3 2026 · Feb 28, 2025 $0.00
Net Income Q3 2026 · Feb 28, 2026 −$19.08K
Net Income Q3 2026 · Feb 28, 2026 −$50.9K
Net Income Q3 2026 · Feb 28, 2025 $80.13K
Net Income restated Q3 2026 · Feb 28, 2025 $80.66K
Operating Income Q3 2026 · Feb 28, 2026 −$237.01K
Operating Income Q3 2026 · Feb 28, 2026 −$268.82K
Operating Income Q3 2026 · Feb 28, 2025 $6.98K
Operating Income Q3 2026 · Feb 28, 2025 −$6.88K
Gross Profit Q3 2026 · Feb 28, 2026 −$62.11K
Gross Profit Q3 2026 · Feb 28, 2026 −$62.11K
Gross Profit Q3 2026 · Feb 28, 2025 $0
Gross Profit Q3 2026 · Feb 28, 2025 $3.75K
Cost Of Revenue Q3 2026 · Feb 28, 2026 $62.11K
Cost Of Revenue Q3 2026 · Feb 28, 2026 $62.11K
Cost Of Revenue Q3 2026 · Feb 28, 2025 $0
Cost Of Revenue Q3 2026 · Feb 28, 2025 $0
Revenue Q3 2026 · Feb 28, 2026 $0
Revenue Q3 2026 · Feb 28, 2026 $0
Revenue Q3 2026 · Feb 28, 2025 $0
Revenue Q3 2026 · Feb 28, 2025 $3.75K